FDA — authorised 18 September 1961
- Application: NDA012813
- Marketing authorisation holder: ALLERGAN
- Local brand name: BLEPHAMIDE
- Indication: SUSPENSION — OPHTHALMIC
- Status: approved
🇺🇸 Blephamide in United States
FDA authorised Blephamide on 18 September 1961
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Blephamide approved in United States?
Yes. FDA authorised it on 18 September 1961; FDA has authorised it.
Who is the marketing authorisation holder for Blephamide in United States?
ALLERGAN holds the US marketing authorisation.